The only reason GK did this type of funding is because they are...

The only reason GK did this type of funding is because they are expecting some significant result which could bring some good deals. He would know more where the Lupin trial stands and how DARRT patients are progressing. Based on this funding action, I think it could be positive. So why didnt he accepted more at 90cents at the last capital raising - he probably thought CEP would be a game changer which it did not produce the results we expected it to be which is a cure. This time is different as we have more patients with Lupin and DARRT and even a patient that had dropped pain level to zero. Surely the 12 months is up for a lot of patients in 800 and 1200mg and Nox would know if the treatment is durable.